This company, established in the early 1980s in South Asia, has a strong focus on innovative drug delivery systems (NDDS). With over three decades of experience, it boasts multiple globally patented technologies and has grown into a significant player in the pharmaceutical sector. The company's portfolio includes a diverse range of products in therapeutic areas like pain management, gynecology, and critical care. It also develops nutraceuticals and nutritional supplements. The company offers a variety of dosage forms, including oral, injectable, and potentially liquid forms. They manufacture products in state-of-the-art facilities, adhering to stringent GMP standards. These facilities hold approvals from international regulatory agencies, including WHO, PIC/S, and ANVISA, and are currently pursuing EU and USFDA certifications. The company's footprint extends across key regions, including Asia, Africa, Latin America, and the CIS. This global reach is further strengthened by a dedicated regulatory, operational, marketing, and business development teams. The company actively engages in licensing agreements with multinational and regional players, demonstrating its commitment to innovation and partnership.

This fast-growing pharmaceutical company boasts a dominant presence in Latin America, Francophone Africa, and a growing footprint in regulated markets like the EU and North America. Founded in 1990, it initially focused on ointments and creams before expanding its product range significantly. With over 4,000 global product licenses, they cater primarily to the "Bottom of the Pyramid" through their owned distribution networks. The company's manufacturing facility holds multiple certifications including US FDA approval (with three successful inspections since 2016), EU-GMP, ANVISA-Brazil, INVIMA-Colombia, and COFEPRIS-Mexico. They prioritize innovation with a significant portion of their earnings invested in research and development of safe and effective products across various dosage forms. Key therapy areas are not specified.

This pharmaceutical company has two decades of experience manufacturing cost-effective medications across various therapeutic areas. Their product portfolio includes tablets, capsules, injectables, liquid orals, and topical solutions. They specialize in expert formulation development and possess advanced analytical capabilities to ensure quality and regulatory compliance. The company's key markets include the EU and North America. Their GMP certified manufacturing facility is strategically located near a major commercial hub.